FDA Proposes Talc Testing for Asbestos

(Reuters) – The U.S. Food and Drug Administration (FDA) is recommending standardized testing methods for detecting asbestos in cosmetics containing talc, as revealed in documents released on Thursday.

Importance

Asbestos is a recognized human carcinogen and poses potential harm to consumers since there is no safe exposure level. Finalizing this rule could protect consumers from asbestos-related illnesses, such as lung and ovarian cancers.

Context

Johnson & Johnson (NYSE: JNJ) faces lawsuits from over 62,000 claimants claiming that its baby powder and other talc products were contaminated with asbestos, leading to cancers. The company is exploring a $10 billion bankruptcy settlement and maintains its products are safe.

The FDA's proposed regulation would mandate manufacturers to test each batch of talc-containing cosmetics for asbestos using methods like polarized light and transmission electron microscopy. Non-compliance could lead the FDA to classify the product as adulterated under the Federal Food, Drug, and Cosmetic Act.

Next Steps

The FDA is inviting public and industry feedback on this proposal over the next 90 days before finalizing any requirements.